2013/2017 H7N9 Prime-Boost Interval

NCT03589807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

NIH

Sponsor class

Conditions

Avian Influenza
Influenza Immunisation

Interventions

BIOLOGICAL: A/H7N9
DRUG: AS03
BIOLOGICAL: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013
OTHER: Phosphate Buffered Saline (PBS) diluent

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)